| 18 Mar 2016 | XOMA XOMA Corp | Paul D Rubin VP Clinical Dev. and CMO | Sale | 24,194 | $0.78 | $18,871 18 Mar 2016 | 326,601 | ↗ |
| 14 Aug 2015 | XOMA XOMA Corp | Paul D Rubin VP Clinical Dev. and CMO | Option | 26,748 | $0.83 | $22,201 14 Aug 2015 | 149,093 | ↗ |
| 15 Jul 2015 | XOMA XOMA Corp | Paul D Rubin VP Clinical Dev. and CMO | Option | 5,000 | $3.04 | $15,200 15 Jul 2015 | 127,345 | ↗ |
| 9 Jul 2015 | XOMA XOMA Corp | Paul D Rubin VP Clinical Dev. and CMO | Option | 33,400 | $3.04 | $101,536 9 Jul 2015 | 151,345 | ↗ |
| 23 Mar 2015 | XOMA XOMA Corp | Paul D Rubin VP Clinical Dev. and CMO | Sale | 32,742 | $3.94 | $129,003 23 Mar 2015 | 119,467 | ↗ |
| 18 Mar 2015 | XOMA XOMA Corp | Paul D Rubin VP Clinical Dev. and CMO | Option | 30,346 | $3.98 | $120,777 18 Mar 2015 | 172,744 | ↗ |
| 15 Dec 2014 | XOMA XOMA Corp | Paul D Rubin VP Clinical Dev. and CMO | Option | 1,600 | $3.04 | $4,864 15 Dec 2014 | 73,621 | ↗ |
| 20 Nov 2014 | XOMA XOMA Corp | Paul D Rubin VP Clinical Dev. and CMO | Option | 5,000 | $3.04 | $15,200 20 Nov 2014 | 77,021 | ↗ |
| 28 Oct 2014 | XOMA XOMA Corp | Paul D Rubin VP Clinical Dev. and CMO | Option | 5,000 | $3.04 | $15,200 28 Oct 2014 | 77,021 | ↗ |
| 15 Sep 2014 | XOMA XOMA Corp | Paul D Rubin VP Clinical Dev. and CMO | Option | 5,000 | $3.04 | $15,200 15 Sep 2014 | 77,021 | ↗ |
| 4 Sep 2014 | XOMA XOMA Corp | Paul D Rubin VP Clinical Dev. and CMO | Option | 10,000 | $3.04 | $30,400 4 Sep 2014 | 82,021 | ↗ |
| 14 Aug 2014 | XOMA XOMA Corp | Paul D Rubin VP Clinical Dev. and CMO | Option | 26,748 | $4.32 | $115,551 14 Aug 2014 | 98,769 | ↗ |
| 16 Jun 2014 | XOMA XOMA Corp | Paul D Rubin VP Clinical Dev. and CMO | Sale | 11,580 | $4.54 | $52,573 16 Jun 2014 | 72,021 | ↗ |
| 28 May 2014 | XOMA XOMA Corp | Paul D Rubin VP Clinical Dev. and CMO | Option | 4,667 | $4.14 | $19,321 28 May 2014 | 85,386 | ↗ |
| 13 May 2014 | XOMA XOMA Corp | Paul D Rubin VP Clinical Dev. and CMO | Sale | 10,000 | $3.84 | $38,400 13 May 2014 | 80,719 | ↗ |
| 18 Mar 2014 | XOMA XOMA Corp | Paul D Rubin VP Clinical Dev. and CMO | Option | 36,347 | $0.50 | $18,174 18 Mar 2014 | 96,719 | ↗ |
| 18 Feb 2014 | XOMA XOMA Corp | Paul D Rubin VP Clinical Dev. and CMO | Option | 6,000 | $3.04 | $18,240 18 Feb 2014 | 9,228 | ↗ |
| 21 Jan 2014 | XOMA XOMA Corp | Paul D Rubin VP Clinical Dev. and CMO | Sale | 6,000 | $8.27 | $49,620 21 Jan 2014 | 3,228 | ↗ |
| 18 Dec 2013 | XOMA XOMA Corp | Paul D Rubin VP Clinical Dev. and CMO | Option | 6,000 | $3.04 | $18,240 18 Dec 2013 | 9,534 | ↗ |
| 27 Nov 2013 | XOMA XOMA Corp | Paul D Rubin VP Clinical Dev. and CMO | Option | 4,696 | $3.04 | $14,276 27 Nov 2013 | 8,230 | ↗ |
| 18 Nov 2013 | XOMA XOMA Corp | Paul D Rubin VP Clinical Dev. and CMO | Option | 1,304 | $2.36 | $3,077 18 Nov 2013 | 4,838 | ↗ |
| 18 Oct 2013 | XOMA XOMA Corp | Paul D Rubin VP Clinical Dev. and CMO | Option | 746 | $2.36 | $1,761 18 Oct 2013 | 9,534 | ↗ |
| 18 Sep 2013 | XOMA XOMA Corp | Paul D Rubin VP Clinical Dev. and CMO | Sale | 6,000 | $4.53 | $27,180 18 Sep 2013 | 8,329 | ↗ |
| 19 Aug 2013 | XOMA XOMA Corp | Paul D Rubin VP Clinical Dev. and CMO | Sale | 6,000 | $3.74 | $22,440 19 Aug 2013 | 14,329 | ↗ |
| 14 Aug 2013 | XOMA XOMA Corp | Paul D Rubin VP Clinical Dev. and CMO | Option | 26,748 | $3.99 | $106,725 14 Aug 2013 | 30,849 | ↗ |
| 18 Jul 2013 | XOMA XOMA Corp | Paul D Rubin VP Clinical Dev. and CMO | Option | 6,000 | $2.73 | $16,380 18 Jul 2013 | 7,353 | ↗ |
| 28 Jun 2013 | XOMA XOMA Corp | Paul D Rubin VP Clinical Dev. and CMO | Option | 567 | $3.45 | $1,956 28 Jun 2013 | 4,101 | ↗ |
| 28 May 2013 | XOMA XOMA Corp | Paul D Rubin VP Clinical Dev. and CMO | Option | 4,667 | $4.21 | $19,648 28 May 2013 | 8,201 | ↗ |
| 28 Mar 2013 | XOMA XOMA Corp | Paul D Rubin VP Clinical Dev. and CMO | Option | 1,498 | $3.32 | $4,973 28 Mar 2013 | 14,749 | ↗ |
| 18 Mar 2013 | XOMA XOMA Corp | Paul D Rubin VP Clinical Dev. and CMO | Option | 18,205 | $3.31 | $60,259 18 Mar 2013 | 20,241 | ↗ |
| 31 Dec 2012 | XOMA XOMA Corp | Paul D Rubin VP Clinical Dev. and CMO | Option | 833 | $2.28 | $1,899 31 Dec 2012 | 2,036 | ↗ |
| 28 Sep 2012 | XOMA XOMA Corp | Paul D Rubin VP Clinical Dev. and CMO | Option | 542 | $3.51 | $1,902 28 Sep 2012 | 1,203 | ↗ |
| 15 Jun 2012 | XOMA XOMA Corp | Paul D Rubin VP Clinical Dev. and CMO | Option | 661 | $2.83 | $1,871 15 Jun 2012 | 661 | ↗ |
| 30 Mar 2012 | XOMA XOMA Corp | Paul D Rubin VP Clinical Dev. and CMO | Option | 1,229 | $2.63 | $3,232 30 Mar 2012 | 3,887 | ↗ |
| 30 Sep 2011 | XOMA XOMA Corp | Paul D Rubin VP Clinical Dev. and CMO | Option | 1,022 | $1.66 | $1,697 30 Sep 2011 | 1,022 | ↗ |
| 22 Mar 2006 | CRTX Cortexyme Inc | Paul D Rubin President and CEO | Option | 72,933 | $0.38 | $27,715 22 Mar 2006 | 114,303 | ↗ |
| 30 Jan 2006 | CRTX Cortexyme Inc | Paul D Rubin President and CEO | Sale | 5,000 | $6.54 | $32,700 30 Jan 2006 | 41,370 | ↗ |
| 17 Jan 2006 | CRTX Cortexyme Inc | Paul D Rubin President and CEO | Sale | 5,000 | $6.70 | $33,500 17 Jan 2006 | 46,370 | ↗ |
| 3 Jan 2006 | CRTX Cortexyme Inc | Paul D Rubin President and CEO | Sale | 5,000 | $7.12 | $35,600 3 Jan 2006 | 51,370 | ↗ |
| 15 Dec 2005 | CRTX Cortexyme Inc | Paul D Rubin President and CEO | Sale | 5,000 | $6.72 | $33,600 15 Dec 2005 | 56,370 | ↗ |
| 30 Nov 2005 | CRTX Cortexyme Inc | Paul D Rubin President and CEO | Sale | 5,000 | $6.43 | $32,150 30 Nov 2005 | 61,370 | ↗ |
| 15 Nov 2005 | CRTX Cortexyme Inc | Paul D Rubin President and CEO | Sale | 5,000 | $6.78 | $33,900 15 Nov 2005 | 66,370 | ↗ |
| 31 Oct 2005 | CRTX Cortexyme Inc | Paul D Rubin President and CEO | Sale | 5,000 | $7.01 | $35,050 31 Oct 2005 | 71,370 | ↗ |
| 17 Oct 2005 | CRTX Cortexyme Inc | Paul D Rubin President and CEO | Sale | 5,000 | $8.65 | $43,250 17 Oct 2005 | 76,370 | ↗ |
